James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 11,212 shares at $1.59 ($18K) on 2016-04-20, disclosed to the SEC on 2016-04-21.
Open-market sale of $18k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |